Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; JELIS Investigators, Japan. Saito Y, et al. Among authors: itakura h. Atherosclerosis. 2008 Sep;200(1):135-40. doi: 10.1016/j.atherosclerosis.2008.06.003. Epub 2008 Jun 19. Atherosclerosis. 2008. PMID: 18667204 Clinical Trial.
Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study.
Yamamoto A, Arakawa K, Sasaki J, Matsuzawa Y, Takemura K, Tsushima M, Fujinami T, Mabuchi H, Itakura H, Yamada N, Toyota T, Oikawa S; Rosuvastatin Dose-Ranging Trialist Group. Yamamoto A, et al. Among authors: itakura h. J Atheroscler Thromb. 2002;9(1):48-56. doi: 10.5551/jat.9.48. J Atheroscler Thromb. 2002. PMID: 12238638 Free article. Clinical Trial.
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).
Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial. Mabuchi H, et al. Among authors: itakura h. Circ J. 2002 Dec;66(12):1096-100. doi: 10.1253/circj.66.1096. Circ J. 2002. PMID: 12499612 Free article.
Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
Horiuchi H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Horiuchi H, et al. Among authors: itakura h. J Am Geriatr Soc. 2004 Dec;52(12):1981-7. doi: 10.1111/j.1532-5415.2004.52552.x. J Am Geriatr Soc. 2004. PMID: 15571531
Serum lipid survey and its recent trend in the general Japanese population in 2000.
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Kita T. Arai H, et al. Among authors: itakura h. J Atheroscler Thromb. 2005;12(2):98-106. doi: 10.5551/jat.12.98. J Atheroscler Thromb. 2005. PMID: 15942120 Free article.
The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study.
Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Itakura H; J-LIT Study Group. Shimamoto K, et al. Among authors: itakura h. Hypertens Res. 2005 Nov;28(11):879-87. doi: 10.1291/hypres.28.879. Hypertens Res. 2005. PMID: 16555576 Clinical Trial.
Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).
Oikawa S, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Oikawa S, et al. Among authors: itakura h. Atherosclerosis. 2007 Apr;191(2):440-6. doi: 10.1016/j.atherosclerosis.2006.04.017. Epub 2006 Jun 12. Atherosclerosis. 2007. PMID: 16765358
Prevalence of metabolic syndrome in the general Japanese population in 2000.
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, Kita T. Arai H, et al. Among authors: itakura h. J Atheroscler Thromb. 2006 Aug;13(4):202-8. doi: 10.5551/jat.13.202. J Atheroscler Thromb. 2006. PMID: 16908953 Free article.
322 results